Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardinal Health (CAH)
NYSE:CAH
Cardinal Health (CAH) Stock Price & Analysis
2,006 Followers
CAH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$75.98 - $115.52
Previous Close$103.37
Volume2.06M
Average Volume (3M)2.38M
Market Cap
$25.14B
Enterprise Value$25.28B
Total Cash (Recent Filing)$4.59B
Total Debt (Recent Filing)$4.72B
Price to Earnings (P/E)40.7
Beta0.62
Next Earnings
May 02, 2024EPS Estimate
$1.96Last Dividend Ex-Date
Mar 28, 2024Dividend Yield1.94%
Share Statistics
EPS (TTM)2.54
Shares Outstanding243,233,153
10 Day Avg. Volume1,983,419
30 Day Avg. Volume2,375,753
Standard Deviation0.08
R-Squared0.21
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-2.84
Price to Sales (P/S)0.12
Price to Cash Flow (P/CF)5.30
P/FCF Ratio5.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.12
Enterprise Value/Gross Profit0.12
Enterprise Value/Ebitda73.69
Forecast
1Y Price Target
$114.43Price Target Upside10.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Cardinal Health News
PremiumCompany Announcements
Cardinal Health Announces New Business Structure and Segments
PremiumCompany Announcements
Cardinal Health Ends Pharmaceutical Distribution Deal with OptumRx
Bulls Say, Bears Say
Bulls Say
Growth In Specialty BusinessThe specialty business continues to grow, highlighted by the planned acquisition of Specialty Networks which is expected to be accretive to non-GAAP EPS 12 months following.
Long-Term Financial StabilityCardinal Health shows a clear ability to sustain elevated growth versus historical levels, which is not fully reflected in relative multiples despite recent outperformance.
Positive Financial PerformanceAdjusted EPS of $1.82 beat estimates, and the company boosted FY2024 EPS guidance, reflecting management's confidence in achieving its financial targets.
Bears Say
Contract LossThe unexpected end of the pharmaceutical distribution contract between Cardinal Health and OptumRx may escalate concerns over increasing competitive intensity in the industry.
Earnings ImpactThe loss of the OptumRx contract is anticipated to negatively affect Cardinal Health's earnings per share from the next fiscal year, signifying a potential downturn in financial performance.
Operational ChallengesCardinal Health faces operational headwinds with reports of higher than expected operating expenses and weaker than projected core growth in the Medical segment.
---
Ownership Overview
3.93% Insiders
23.99% Mutual Funds
28.45% Other Institutional Investors
43.64% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CAH FAQ
What was Cardinal Health’s price range in the past 12 months?
Cardinal Health lowest stock price was $75.98 and its highest was $115.52 in the past 12 months.
What is Cardinal Health’s market cap?
Currently, no data Available
When is Cardinal Health’s upcoming earnings report date?
Cardinal Health’s upcoming earnings report date is May 02, 2024 which is in 7 days.
How were Cardinal Health’s earnings last quarter?
Cardinal Health released its earnings results on Feb 01, 2024. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.597 by $0.223.
Is Cardinal Health overvalued?
According to Wall Street analysts Cardinal Health’s price is currently Undervalued.
Does Cardinal Health pay dividends?
Cardinal Health pays a Quarterly dividend of $0.5 which represents an annual dividend yield of 1.94%. See more information on Cardinal Health dividends here
What is Cardinal Health’s EPS estimate?
Cardinal Health’s EPS estimate is $1.96.
How many shares outstanding does Cardinal Health have?
Cardinal Health has 243,233,150 shares outstanding.
What happened to Cardinal Health’s price movement after its last earnings report?
Cardinal Health reported an EPS of $1.82 in its last earnings report, beating expectations of $1.597. Following the earnings report the stock price went down -3.744%.
Which hedge fund is a major shareholder of Cardinal Health?
Among the largest hedge funds holding Cardinal Health’s share is Elliott Investment Management LP. It holds Cardinal Health’s shares valued at 202M.
---
Cardinal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$114.43 (10.52% Upside)
$114.43 (10.52% Upside)
Blogger Sentiment
Bullish
CAH Sentiment 88%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 665.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.76%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
4.70%
Trailing 12-Months
Company Description
Cardinal Health
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The company operates through the following segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products. The Medical segment manufactures, sources and distributes cardinal health branded medical, surgical and laboratory products. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
---
CAH Company Deck
---
CAH Earnings Call
Q2 2024
0:00 / 0:00
---
CAH Revenue Breakdown
92.68% Pharmaceutical
7.32% Medical
---
CAH Stock 12 Months Forecast
Average Price Target
$114.43
▲(10.52% Upside)
Technical Analysis
Best Analysts Covering CAH
1 Year
1 Year Success Rate
10/11 ratings generated profit
1 Year Average Return
+20.48%
reiterated a buy rating 3 months ago
Copying Kevin Caliendo's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +20.48% per trade.
---